Decheng Capital Management III (Cayman), LLC

Grand Cayman, E9 · CIK 1747821 · 13F filing filed 2023-12-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$299.6m reported value -6.0% vs Q2 2023

26positions

79.2%in top 10

9 new 1 added 2 reduced 8 sold out vs Q2 2023

Holdings, Q3 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	ALPINE IMMUNE SCIENCES INC COM NVLS	NVLS	6,708,288	$76.8m25.63%	25.63%	New
2	ZENTALIS PHARMACEUTICALS INC COM ZNTL	ZNTL	2,099,583	$42.1m14.06%	14.06%	Unchanged
3	AURA BIOSCIENCES INC COM AURA	AURA	1,163,123	$18.2m6.09%	6.09%	Added +869.8k	+869,790 296.5%
4	ROIVANT SCIENCES LTD SHS ROIV	ROIV	1,459,700	$17.0m5.69%	5.69%	New
5	ACELYRIN INC COM COM		1,548,317	$15.7m5.26%	5.26%	Reduced -6.1k	-6,100 -0.4%
6	ARCUS BIOSCIENCES INC COM RCUS	RCUS	869,790	$15.6m5.21%	5.21%	Unchanged
7	10X GENOMICS INC CL A COM TXG	TXG	359,554	$14.8m4.95%	4.95%	Unchanged
8	ARGENX SE SPONSORED ADR ARGX	ARGX	27,429	$13.5m4.50%	4.50%	Unchanged
9	PACIFIC BIOSCIENCES CALIF IN COM PACB	PACB	1,463,872	$12.2m4.08%	4.08%	Unchanged
10	ILLUMINA INC COM ILMN	ILMN	80,859	$11.1m3.70%	3.70%	Unchanged
11	LANTHEUS HLDGS INC COM LNTH	LNTH	142,196	$9.9m3.30%	3.30%	New
12	HORIZON THERAPEUTICS PUB L SHS HZNP	HZNP	78,900	$9.1m3.05%	3.05%	Unchanged
13	PHATHOM PHARMACEUTICALS INC COM PHAT	PHAT	850,000	$8.8m2.94%	2.94%	Unchanged
14	IMMUNOGEN INC COM IMGN	IMGN	415,880	$6.6m2.20%	2.20%	New
15	SEAGEN INC COM SGEN	SGEN	23,014	$4.9m1.63%	1.63%	New
16	CUE HEALTH INC COM HLTHQ	HLTHQ	8,980,909	$4.0m1.32%	1.32%	Unchanged
17	BEYONDSPRING INC SHS BYSI	BYSI	4,958,143	$4.0m1.32%	1.32%	New
18	TERNS PHARMACEUTICALS INC COM COM		714,285	$3.6m1.20%	1.20%	Unchanged
19	EQUILLIUM INC COM EQ	EQ	4,447,308	$3.3m1.10%	1.10%	Unchanged
20	AADI BIOSCIENCE INC COM WHWK	WHWK	526,329	$2.5m0.85%	0.85%	Unchanged
21	ATRICURE INC COM ATRC	ATRC	46,259	$2.0m0.68%	0.68%	New
22	SCYNEXIS INC COM NEW COM NEW		555,555	$1.3m0.42%	0.42%	Unchanged
23	MERSANA THERAPEUTICS INC COM COM		904,268	$1.1m0.38%	0.38%	Unchanged
24	PYXIS ONCOLOGY INC COMMON STOCK PYXS	PYXS	326,810	$650.4k0.22%	0.22%	New
25	GENEDX HOLDINGS CORP COM CL A WGS	WGS	103,604	$377.1k0.13%	0.13%	New
26	ADICET BIO INC COM COM		200,201	$274.3k0.09%	0.09%	Reduced -305.5k	-305,467 -60.4%

Sold out since Q2 2023

Security	Ticker	Shares held before	Value then
Alpine Immune Sciences, Inc. SO 5.2 PERP	SO 5.2 PERP	6,708,288	$69.0m6.7m shares
ROIVANT SCIENCES LTD		1,459,700	$14.7m1.5m shares
BeyondSpring Inc.		4,958,143	$5.9m5.0m shares
SEATTLE GENETICS INC SGEN	SGEN	23,014	$4.4m23.0k shares
AtriCure Inc.		46,259	$2.3m46.3k shares
APEXIGEN INC		1,894,551	$814.3k1.9m shares
SEMA4 HOLDINGS CORP SMFR	SMFR	103,604	$617.5k103.6k shares
NEUBASE THERAPEUTICS INC		50,000	$92.5k50.0k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

Company	Ticker	Stake	Change	Schedule	Last filed
BEYONDSPRING INC BYSI · 13G · filed 2026-02-13	BYSI	9.2%≈ $6.7m	-2.0 pts	13G	2026-02-13